You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 9, March 4, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Making Insurance Coverage for New Technologies Reasonable and Accountable

James E. Sabin, MD; Norman Daniels, PhD

JAMA. 1998;279:703-704.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The central policy challenge for reform of the US health care system in the next decade will be helping society come to grips with the unsolved problem of meeting patient needs fairly under reasonable resource constraints. Providing an excellent level of care to all within acceptable levels of expenditure will require a new way of thinking about quality1 and a much more open forum for public reflection and debate.2 Unfortunately, with the notable exception of the state of Oregon, US political dialogue to date has been characterized more by avoidance and wish fulfillment than by realistic analysis and openly acknowledged hard choices. As a nation we are in the very early stages of a learning curve regarding setting limits and talking candidly about rationing.

Decisions about the adoption and application of expensive new treatments are a central component of both quality planning and . . . [Full Text of this Article]

From the Center for Ethics in Managed Care, Harvard Pilgrim Health Care and Harvard Medical School, and Department of Psychiatry, Harvard Medical School (Dr Sabin), and the Department of Philosophy, Tufts University (Dr Daniels), Boston, Mass.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Can A Center For Comparative Effectiveness Information Succeed? Perspectives From A Health Care Company
Buto and Juhn
Health Aff (Millwood) 2006;25:w586-w588.
ABSTRACT | FULL TEXT  

Managed Care: Strengthening the Consumer Voice in Managed Care: I. Can the Private Sector Meet the Public-Sector Standard?
Sabin and Daniels
Psychiatr. Serv. 2001;52:461-464.
FULL TEXT  

Growth and Determinants of Access in Patient E-mail and Internet Use
Mandl et al.
Arch Pediatr Adolesc Med 2000;154:508-511.
ABSTRACT | FULL TEXT  

Physician Recommendations vs Insurance Coverage for Growth Hormone
Berman et al.
JAMA 1998;280:1052-1054.
FULL TEXT  

Growth Hormone Therapy: Physicians vs. Insurers
JWatch Psychiatry 1998;1998:20-20.
FULL TEXT  

Physician Recommendations vs. Insurer Coverage for Growth Hormone Therapy
JWatch General 1998;1998:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.